Part One Introduction to biocompatibility in medical devices 000
1 Strategies to accelerate medical market access and manage risks of biocompatibility R. Eloy and S.J. Goldenberg
2 Making use of a biological safety evaluation plan D. Parente
3 Biomechanical and biochemical compatibility in innovative biomaterials J. Huang, X. Li, and Z.X. Guo
Part Two Evaluation and characterization of biocompatibility in medical devices
4 A practical approach to analytical chemistry of medical devices D.E. Albert
5 Tolerable intake values for leachables: Practical use of ISO 10993-17 standard R.P. Brown
6 In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices W.H. De Jong, J.W. Carraway, and R.E. Geertsma
7 Practical approach to blood compatibility assessments: General considerations and standards M.F. Wolf and J.M. Anderson
8 Quality strategies that fasten devices access to global markets J.A. Torfin and S. Gompertz
9 Accelerating medical device biocompatibility evaluation: An industry perspective K.P. Coleman, W.V. Christian, and W. Zhang
10 Overcoming negative test results during manufacture D. Parente
11 Methods for the characterization and evaluation of drug-device combination products A.L. Lewis
Part Three Testing and interpreting the performance of medical devices
12 Efficient evaluations of bone implants performances J.-P. Boutrand
13 Methods and interpretation of performance studies for dental implants M. Dard
14 Optimizing the design of preclinical safety and performance studies-Examples in soft tissues and cardio-vascular implants E. Drevon-Gaillot, T. Blair, and G. Clermont
15 Mechanical testing for soft and hard tissue implants C. Kaddick
Part Four International regulation of medical devices
16 Biological evaluation and regulation of medical devices in the European Union T. Keene
17 Biological evaluation and regulation of medical devices in Japan K. Kojima and K. Sakaguchi
18 Medical device regulations in China C. Shan and M. Liu
Part Five Histopathology principles for biocompatibility and performance studies
19 Current considerations in medical device pathology A. Alves, L. Wancket, A. Metz
Jean-Pierre Boutrand is General Manager and Scientific Director for the European division of NAMSA (the world leading medical device evaluation company). Dr Boutrand has been involved in more than 100 public presentations and publications on topics related to medical device evaluation and is registered as an expert on the biological safety of medical devices for ANSM (the French agency for the safety of health products).